Manufacturer record
Anant Pharmaceuticals G.T. Road: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Anant Pharmaceuticals G.T. Road was declared Not of Standard Quality in June 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ALT-0432, Ceeti-LM (Levocetirizine & Montelukast Sodium Tablets I.P.) (exp Nov 2024). RDTL Guwahati (state lab) found it not of standard quality: Dissolution of Montelukast and Levocetirizine Hydrochloride. Listed in the June 2023 alert.
Records by type
1 record linked to Anant Pharmaceuticals G.T. Road in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ceeti-LM (Levocetirizine & Montelukast Sodium Tablets I.P.) | Batch ALT-0432Mfg Dec 2022 · Exp Nov 2024 | Dissolution of Montelukast and Levocetirizine HydrochlorideDissolution | RDTL GuwahatiState lab | Jun 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.